Jiangsu Sihuan Bioengineering Co., Ltd
Shenzhen Stock ExchangeTotal Valuation
Jiangsu Sihuan Bioengineering Co., Ltd carries a market capitalization of 3.63B, placing it among publicly traded companies globally. Its enterprise value stands at 2.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.63B |
| Enterprise Value | 2.63B |
Share Statistics
Jiangsu Sihuan Bioengineering Co., Ltd currently has 1.03B shares outstanding.
| Shares Outstanding | 1.03B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 9.40, and the price-to-book ratio stands at 9.14.
| PE Ratio | N/A |
| PS Ratio | 9.40 |
| PB Ratio | 9.14 |
| P/TBV Ratio | 6.96 |
| P/FCF Ratio | 456.82 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 9.42 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 312.76 |
Financial Position
Jiangsu Sihuan Bioengineering Co., Ltd maintains a current ratio of 4.01, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.99, indicating elevated leverage, while an interest coverage ratio of -11.63 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.01 |
| Quick Ratio | 0.48 |
| Debt / Equity | 6.99 |
| Debt / EBITDA | -0.87 |
| Interest Coverage | -11.63 |
Financial Efficiency
| Return on Equity (ROE) | -31.87 |
| Return on Assets (ROA) | -18.60 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.46 |
Taxes
| Income Tax | -445,378.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Jiangsu Sihuan Bioengineering Co., Ltd's stock has gained approximately 38.97638% over the past 52 weeks. The 50-day moving average sits at 3.29, while the 200-day moving average is 2.78.
| Beta (5Y) | N/A |
| 52-Week Price Change | 38.97638% |
| 50-Day Moving Average | 3.29 |
| 200-Day Moving Average | 2.78 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Jiangsu Sihuan Bioengineering Co., Ltd generated 279.61M in revenue and converted that into -109.03M in net income, yielding earnings per share of -0.11. EBITDA reached -31.14M, while operating income came in at -31.14M.
| Revenue | 279.61M |
| Gross Profit | 119.97M |
| Operating Income | -31.14M |
| Pretax Income | -113.00M |
| Net Income | -109.03M |
| EBITDA | -31.14M |
| EBIT | -31.14M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
Jiangsu Sihuan Bioengineering Co., Ltd holds 48.73M in cash and equivalents against 27.17M in total debt, resulting in a net debt position of -48.59M. Total book value stands at 287.57M, with working capital of 304.73M providing operational flexibility.
| Cash & Cash Equivalents | 48.73M |
| Total Debt | 27.17M |
| Net Debt | -48.59M |
| Equity (Book Value) | 287.57M |
| Book Value Per Share | 0.28 |
| Working Capital | 304.73M |
Cash Flow
After subtracting -5.75M in capital expenditures, free cash flow totaled -5.75M - equivalent to -0.01 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -5.75M |
| Free Cash Flow | -5.75M |
| FCF Per Share | -0.01 |
Margins
Jiangsu Sihuan Bioengineering Co., Ltd operates with a gross margin of 42.91, reflecting its pricing power and cost economics. The operating margin of -11.14 and net profit margin of -39.00 provide insight into operational efficiency.
| Gross Margin | 42.91 |
| Operating Margin | -11.14 |
| Pretax Margin | -40.41 |
| Profit Margin | -39.00 |
| EBITDA Margin | -11.14 |
Dividends & Yields
The company's payout ratio of -0.48 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | -0.48 |
| Shareholder Yield | 0.74 |
| FCF Yield | 0.22 |
Stock Splits
Jiangsu Sihuan Bioengineering Co., Ltd's most recent stock split took place on August 26, 2003 with a 1:2 split ratio.
| Last Split Date | 8/26/2003 |
| Split Ratio | 1:2 |
Scores
Jiangsu Sihuan Bioengineering Co., Ltd posts an Altman Z-Score of 10.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.70 |